Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)
Clinical trial NCT05549167 · RECRUITING
Trial details
- NCT number
- NCT05549167
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2029-09-30
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.